Document is current

Article History

Received: 16 November 2024

Accepted: 3 February 2025

First Online: 2 April 2025

Declarations

:

: Ethics approval was obtained on March 1st, 2022, from the Ethics Review Board (ERB) Comité de Ética de la Investigación con medicamentos (CEIM) Hospital Clinic Barcelona.Participants were provided with written information about the study and were invited to participate. Participation was voluntary, there were no direct benefits for participation nor negative consequences for declining to participate. Participants agreeing to participate provided written consent and signed an Informed Consent Form (ICF).

: Not applicable.

: The authors declare no competing interests.